Stokes Family Office LLC Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stokes Family Office LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 855 shares of the medical equipment provider’s stock after selling 357 shares during the period. Stokes Family Office LLC’s holdings in Intuitive Surgical were worth $288,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. OFI Invest Asset Management bought a new position in shares of Intuitive Surgical in the third quarter worth $25,000. Baystate Wealth Management LLC grew its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC increased its position in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares during the period. Headinvest LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $28,000. Finally, Stone House Investment Management LLC boosted its position in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 50 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.0 %

ISRG stock traded up $3.71 during midday trading on Friday, hitting $381.36. The company had a trading volume of 1,028,858 shares, compared to its average volume of 1,492,254. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock has a market cap of $135.27 billion, a price-to-earnings ratio of 68.84, a PEG ratio of 4.88 and a beta of 1.39. The stock’s 50 day moving average price is $385.56 and its 200 day moving average price is $348.56.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the prior year, the company posted $1.00 EPS. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Raymond James upped their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Mizuho lifted their price target on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Finally, BTIG Research boosted their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $375.39, for a total transaction of $141,146.64. Following the transaction, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,067,272.73. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $375.39, for a total value of $141,146.64. Following the completion of the transaction, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,067,272.73. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders have sold 226,928 shares of company stock valued at $87,833,828 over the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.